172 related articles for article (PubMed ID: 8139841)
21. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
Herr HW
J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743
[TBL] [Abstract][Full Text] [Related]
22. Holmium laser resection of bladder tumors (HoLRBT).
Das A; Gilling P; Fraundorfer M
Tech Urol; 1998 Mar; 4(1):12-4. PubMed ID: 9568769
[TBL] [Abstract][Full Text] [Related]
23. The use of local anesthesia with N-DO injector (Physion) for transurethral resection (TUR) of bladder tumors and bladder mapping: preliminary results and cost-effectiveness analysis.
Brausi MA; Verrini G; De Luca G; Viola M; Simonini GL; Peracchia G; Gavioli M
Eur Urol; 2007 Nov; 52(5):1407-11. PubMed ID: 17507152
[TBL] [Abstract][Full Text] [Related]
24. Transurethral prostatic resection or laser therapy for men with acute urinary retention: the ClasP randomized trial.
Chacko KN; Donovan JL; Abrams P; Peters TJ; Brookes ST; Thorpe AC; Gujral S; Wright M; Kennedy LG; Neal DE
J Urol; 2001 Jul; 166(1):166-70; discussion 170-1. PubMed ID: 11435848
[TBL] [Abstract][Full Text] [Related]
25. Early complications of endoscopic treatment for superficial bladder tumors.
Collado A; Chéchile GE; Salvador J; Vicente J
J Urol; 2000 Nov; 164(5):1529-32. PubMed ID: 11025697
[TBL] [Abstract][Full Text] [Related]
26. Transurethral resection for muscle-invasive bladder cancer.
Kondás J; Váczi L; Szecsó L; Kondér G
Int Urol Nephrol; 1993; 25(6):557-63. PubMed ID: 8175277
[TBL] [Abstract][Full Text] [Related]
27. The value of a second transurethral resection for T1 bladder cancer.
Schwaibold HE; Sivalingam S; May F; Hartung R
BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814
[TBL] [Abstract][Full Text] [Related]
28. [Initial experiences with the neodym YAG laser in urology].
Maier U; Kautzky W
Wien Klin Wochenschr; 1984 Jan; 96(2):73-6. PubMed ID: 6711000
[TBL] [Abstract][Full Text] [Related]
29. A contribution to the special discussion on YAG laser irradiation of superficial bladder cancer.
Beisland HO
Acta Urol Belg; 1989; 57(3):693-5. PubMed ID: 2816584
[TBL] [Abstract][Full Text] [Related]
30. Microinvasive Nd:YAG laser therapy of early glottic carcinoma and its effect on soluble interleukin-2 receptor, interleukin-2, and natural killer cells.
Lai JP; Tao ZD; Xiao JY; Chen XH; Zhao SP; Tian YQ; Betz CS
Laryngoscope; 2001 Sep; 111(9):1585-8. PubMed ID: 11568609
[TBL] [Abstract][Full Text] [Related]
31. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
Herr HW; Donat SM; Dalbagni G
J Urol; 2007 Jan; 177(1):75-9; discussion 79. PubMed ID: 17162005
[TBL] [Abstract][Full Text] [Related]
32. Thulium laser resection via a flexible cystoscope for recurrent non-muscle-invasive bladder cancer: initial clinical experience.
Gao X; Ren S; Xu C; Sun Y
BJU Int; 2008 Nov; 102(9):1115-8. PubMed ID: 18565172
[TBL] [Abstract][Full Text] [Related]
33. How to teach the teacher to teach the TUR-B.
Pycha A; Palermo S
Int J Surg; 2007 Apr; 5(2):81-5. PubMed ID: 17448969
[TBL] [Abstract][Full Text] [Related]
34. [The surgical results in malignant bladder tumors using the Scalpel-1 carbon-dioxide laser].
Dmitriev BV; Nikol'skiĭ AD; Latyshev MM; Zolin VP; Sanevich RA
Urol Nefrol (Mosk); 1997; (1):25-8. PubMed ID: 9123661
[TBL] [Abstract][Full Text] [Related]
35. [Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation].
Honda M; Satoh M; Tujimoto Y; Takada T; Matsumiya K; Fujioka H
Hinyokika Kiyo; 2006 May; 52(5):331-5. PubMed ID: 16758720
[TBL] [Abstract][Full Text] [Related]
36. Comparative study on a single treatment response to long pulse Nd:YAG lasers and intense pulse light therapy for hair removal on skin type IV to VI--is longer wavelengths lasers preferred over shorter wavelengths lights for assisted hair removal.
Goh CL
J Dermatolog Treat; 2003 Dec; 14(4):243-7. PubMed ID: 14660273
[TBL] [Abstract][Full Text] [Related]
37. [Results of BCG in the treatment of pTa and pT1 bladder tumors. Evaluation of a long protocol using 75 mg of Pasteur strain BCG].
Ayed M; Ben Hassine L; Ben Slama R; Chelbi N; Ghozzi S; Drissi H; Jemni M; Chebil M
Prog Urol; 1998 Apr; 8(2):206-10. PubMed ID: 9615929
[TBL] [Abstract][Full Text] [Related]
38. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
39. Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors.
Colombo R; Da Pozzo LF; Lev A; Salonia A; Rigatti P; Leib Z; Servadio C; Caldarera E; Pavone-Macaluso M
J Urol; 1998 Mar; 159(3):783-7. PubMed ID: 9474148
[TBL] [Abstract][Full Text] [Related]
40. A second-look TUR in T1 transitional cell carcinoma: why?
Jakse G; Algaba F; Malmström PU; Oosterlinck W
Eur Urol; 2004 May; 45(5):539-46; discussion 546. PubMed ID: 15082193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
